These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1084 related items for PubMed ID: 15569117

  • 1. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
    Annese V, Piepoli A, Perri F, Lombardi G, Latiano A, Napolitano G, Corritore G, Vandewalle P, Poulain D, Colombel JF, Andriulli A.
    Aliment Pharmacol Ther; 2004 Nov 15; 20(10):1143-52. PubMed ID: 15569117
    [Abstract] [Full Text] [Related]

  • 2. Familial expression of anti-Saccharomyces cerevisiae Mannan antibodies in Crohn's disease and ulcerative colitis: a GISC study.
    Annese V, Andreoli A, Andriulli A, Dinca R, Gionchetti P, Latiano A, Lombardi G, Piepoli A, Poulain D, Sendid B, Colombel JF.
    Am J Gastroenterol; 2001 Aug 15; 96(8):2407-12. PubMed ID: 11513182
    [Abstract] [Full Text] [Related]

  • 3. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease.
    Koutroubakis IE, Petinaki E, Mouzas IA, Vlachonikolis IG, Anagnostopoulou E, Castanas E, Maniatis AN, Kouroumalis EA.
    Am J Gastroenterol; 2001 Feb 15; 96(2):449-54. PubMed ID: 11232689
    [Abstract] [Full Text] [Related]

  • 4. Antibodies to Saccharomyces cerevisiae: are they useful in clinical practice?
    Candelli M, Papa A, Nista EC, Danese S, Armuzzi A, Bartolozzi F, Tondi P, Ojetti V, Gasbarrini G, Gasbarrini A.
    Hepatogastroenterology; 2003 Feb 15; 50(51):718-20. PubMed ID: 12828069
    [Abstract] [Full Text] [Related]

  • 5. Antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies in inflammatory bowel diseases.
    Kiliç ZM, Tunç B, Ayaz S, Filik L, Aktaş S, Parlak E, Ulker A.
    Turk J Gastroenterol; 2004 Dec 15; 15(4):238-42. PubMed ID: 16249978
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.
    Peeters M, Joossens S, Vermeire S, Vlietinck R, Bossuyt X, Rutgeerts P.
    Am J Gastroenterol; 2001 Mar 15; 96(3):730-4. PubMed ID: 11280542
    [Abstract] [Full Text] [Related]

  • 7. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
    Zholudev A, Zurakowski D, Young W, Leichtner A, Bousvaros A.
    Am J Gastroenterol; 2004 Nov 15; 99(11):2235-41. PubMed ID: 15555007
    [Abstract] [Full Text] [Related]

  • 8. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease.
    Dotan I, Fishman S, Dgani Y, Schwartz M, Karban A, Lerner A, Weishauss O, Spector L, Shtevi A, Altstock RT, Dotan N, Halpern Z.
    Gastroenterology; 2006 Aug 15; 131(2):366-78. PubMed ID: 16890590
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antineutrophil cytoplasmic antibodies in Estonian patients with inflammatory bowel disease. Prevalence and diagnostic role.
    Kull K, Salupere R, Uibo R, Ots M, Salupere V.
    Hepatogastroenterology; 1998 Aug 15; 45(24):2132-7. PubMed ID: 9951879
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic role of anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic antibodies in patients with inflammatory bowel disease.
    Kim BG, Kim YS, Kim JS, Jung HC, Song IS.
    Dis Colon Rectum; 2002 Aug 15; 45(8):1062-9. PubMed ID: 12195191
    [Abstract] [Full Text] [Related]

  • 16. Ethnic and socio-cultural specificities in Tunisia have no impact on the prevalence of anti-Saccharomyces cerevisiae antibodies in Crohn's disease patients, their relatives or associated clinical factors.
    Hadrich I, Vandewalle P, Cheikhrouhou F, Makni F, Krichen MS, Sendid B, Standaert-Vitse A, Ayadi A, Poulain D.
    Scand J Gastroenterol; 2007 Jun 15; 42(6):717-25. PubMed ID: 17505994
    [Abstract] [Full Text] [Related]

  • 17. Clinical significance of anti-Saccharomyces cerevisiae antibody (ASCA) in Korean patients with Crohn's disease and its relationship to the disease clinical course.
    Kim BC, Park S, Han J, Kim JH, Kim TI, Kim WH.
    Dig Liver Dis; 2007 Jul 15; 39(7):610-6. PubMed ID: 17531556
    [Abstract] [Full Text] [Related]

  • 18. Detection of antisynthetic mannoside antibodies (ASigmaMA) reveals heterogeneity in the ASCA response of Crohn's disease patients and contributes to differential diagnosis, stratification, and prediction.
    Vandewalle-El Khoury P, Colombel JF, Joossens S, Standaert-Vitse A, Collot M, Halfvarson J, Ayadi A, Landers CJ, Vermeire S, Rutgeerts P, Targan SR, Chamaillard M, Mallet JM, Sendid B, Poulain D.
    Am J Gastroenterol; 2008 Apr 15; 103(4):949-57. PubMed ID: 18047546
    [Abstract] [Full Text] [Related]

  • 19. Serological differentiation of inflammatory bowel diseases.
    Conrad K, Schmechta H, Klafki A, Lobeck G, Uhlig HH, Gerdi S, Henker J.
    Eur J Gastroenterol Hepatol; 2002 Feb 15; 14(2):129-35. PubMed ID: 11981336
    [Abstract] [Full Text] [Related]

  • 20. [Initial experience with detection of Saccharomyces cerevisiae antibodies in patients with primary nonspecific inflammatory bowel disease].
    Malícková K, Janatková I, Fucíková T, Adamec S, Lukás M.
    Epidemiol Mikrobiol Imunol; 2001 Aug 15; 50(3):131-5. PubMed ID: 11550421
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.